Results

Total Results: 247 records

Showing results for "laboratory".

101. Archived: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening-september-2016
     September 06, 2016 - Interferon-gamma release assays require a single venous blood sample and laboratory processing within … processing requirements for blood samples and ensure that venous blood samples are drawn and can reach the laboratory

102. Serological Screening for Genital Herpes: A Reaffirmation Evidence Update for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/XW6XUe2wRmkM-6Rrbn_462
     February 01, 2023 - However, the University of Washington Virology Laboratory is the only U.S. site currently offering … Diagnosis of genital herpes simplex virus infection in the clinical laboratory. … Between Sep 2015 and Dec 2021 296 Search for KQ 2 ID Search Items Found #1 [mh "Clinical Laboratory … technique'/exp OR 'laboratory technique' OR 'mass screening'/exp OR 'mass screening' OR 'predictive … Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory

103. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/abTWXPvJyAMcqN9KcEt-vt
     September 06, 2016 - QuantiFERON TB Gold In-Tube IGRA by send- ing 3 blood specimens from each participant to 3 different laboratories … noted to have extensive experience and proficiency with IGRA testing and interpretation.91 Across all 3 laboratories … 7.7% of participants had discordant results (none had indeterminate re- sults); κ values of pairwise laboratory … reliability of IGRA results by processing 2 blood samples from each study par- ticipant (using the same laboratory … Variation in T-SPOT.TB spot interpretation between independent observers from different laboratories.

104. Archived: Evidence Summary: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/genital-herpes-screening-november-2016
     December 20, 2016 - HSV-1 (or other viruses), recent seroconversion, geographic variability in HSV-2 strain variants, and laboratory … Diagnosis of genital herpes simplex virus infection in the clinical laboratory. … WB testing Study participants and serologic samples sent to the University of Washington Virology Laboratory

105. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholerolemia: Evidence Report and Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/dCH2CMqVyAzf4eyj-ch6H3
     August 09, 2016 - All reported clin- ical and laboratory harms associated with lipid-lowering drugs were included. … Trials, cohort studies, and observational studies that reported clinical or laboratory harms were included … placebo,30,31 and homocysteine was increased in children treated with cholestyramine.30,31 No marked laboratory

106. Xt2Uhv4Qyluz8O2Hb A4Yq (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/xt2Uhv4qyLUZ8o2HB_a4YQ
     July 01, 2013 - Conventional HIV test results are available within 1 to 2 days from most commercial laboratories. … sensitivity and specificity, �99.5%), and results are available within 1 to 2 days from most commercial laboratories … had ART-related adverse events more frequently (27% vs. 18%; P � 0.001), particularly grade 3 or 4 laboratory

107. Archived: Evidence Summary: Preeclampsia: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/preeclampsia-screening-april-2017
     April 25, 2017 - -h timed specimen or immediately after timed collection NR (NR) NR, sent to Health Network Laboratories … collections ADVIA total protein urine assay (modified Fujita method) (NR) NR, sent to Health Network Laboratory … or by catheter Pyrogallol red/molybdate (protein); Jaffe rate (creatinine) (Synchron LX Systems) Laboratory … technician 24-h collection via either clean catch or catheter NR (NR) Laboratory technician

108. Archived: Syphilis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-screening-2004
     July 15, 2004 - Nontreponemal tests commonly used for initial screening are the Venereal Disease Research Laboratory

109. Screening for Syphilis Infection - Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/qVACAf9sMmuX48MnnVDcBR
     July 01, 2004 - • Nontreponemal tests commonly used for initial screening are the Venereal Disease Research Laboratory

110. Archived: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-and-ovarian-cancer-brca-testing-screening-2005
     September 15, 2005 - a primary care screening population are available. 30 These risk tools include the Myriad Genetic Laboratories … Myriad Genetic Laboratories, Inc. Accessed at www.myriadtests.com/home.htm on 30 April 2004.

111. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ER_LzXdmdRcZ463r4UrGtz
     September 01, 2005 - These risk tools include the Myriad Genetic Laboratories model, the Couch model, BRCAPRO, and the Tyrer … Myriad Genetic Laboratories, Inc. Accessed at www.myriadtests.com/ home.htm on 30 April 2004. 18.

112. Evidence Summary: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary29/obstructive-sleep-apnea-in-adults-screening
     November 15, 2022 - alone or followed by an unattended home sleep test) compared with polysomnography conducted in a sleep laboratory … For KQ2, studies limited to persons referred to sleep laboratories for suspected OSA were excluded. … measures of discrimination for the MVAP score followed by an unattended home sleep test compared with in-laboratory … First, studies of screening accuracy were required to have used in-laboratory polysomnography as the … 53 (7.7) 20 Black, 59 Caucasian, 40 d 32.1 (7.4) 22.5 (22.9) 100 Of the 79% who had in-laboratory

113. Recommendation: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening
     September 14, 2021 - Gonococcal and nongonococcal urethritis in men: clinical and laboratory differentiation. … Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae

114. Screening for Latent Tuberculosis Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wx_w92ukxeDvNShoRQXbhP
     September 06, 2016 - Interferon-gamma release assays require a single venous blood sample and laboratory processing within … processing requirements for blood samples and ensure that venous blood samples are drawn and can reach the laboratory

115. Archived: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
     March 14, 2014 - specific for assessing coronary heart disease risk, TC alone is an acceptable screening test if available laboratory

116. Archived: Final Evidence Review: Genital Herpes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
     March 15, 2005 - PCR is available at many large laboratories and takes approximately 1 day to process. … 80 to 90 percent for specimens obtained from lesions, although sensitivity and specificity vary by laboratory … Laboratory studies were performed to screen for evidence of toxicity in mothers and infants. … Drugs were well tolerated, and no significant laboratory or clinical evidence of toxicity was detected

117. Screening for Genital Herpes Simplex: A Brief Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZzZp7_aoJn73k9z25w_-qr
     March 01, 2005 - PCR is available at many large laboratories and takes approximately 1 day to process. … Sensitivity is 80% to 90% for specimens obtained from lesions, although sensitivity and specificity vary by laboratory … Laboratory studies were performed to screen for evidence of toxicity in mothers and infants. … Drugs were well tolerated, and no significant laboratory or clinical evidence of toxicity was detected

118. Archived: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-virus-infection-screening-2004
     March 08, 2004 - Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus.

119. untitled (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/VNs-WaxpPcsodxCb57gYmn
     January 03, 2017 - Studies were conducted in a variety of settings (home or laboratory) and used a variety of AHI cutpoints … In some cases, further studies that monitor additional physi- ological variables in a sleep laboratory

120. Archived: Hepatitis C: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening-2013
     June 15, 2013 - USPSTF found more than 100 studies (including 8 of good quality) that compared various noninvasive laboratory-based … of Veterans Affairs that adjusted for several confounders (demographic factors, comorbid conditions, laboratory